PKA alpha cat(Phospho Ser338) Polyclonal Antibody

This gene encodes one of the catalytic subunits of protein kinase A, which exists as a tetrameric holoenzyme with two regulatory subunits and two catalytic subunits, in its inactive form. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. cAMP-dependent phosphorylation of proteins by protein kinase A is important to many cellular processes, including differentiation, proliferation, and apoptosis. Constitutive activation of this gene caused either by somatic mutations, or genomic duplications of regions that include this gene, have been associated with hyperplasias and adenomas of the adrenal cortex and are linked to corticotropin-independent Cushing's syndrome. Altern

Introducing the PKA alpha cat phospho-Ser338 polyclonal antibody, meticulously developed by BT Lab, a renowned name in the field of life sciences. This cutting-edge antibody is designed to specifically target and detect the phosphorylated form of PKA alpha cat at Ser338, enabling researchers to delve deeper into the intricate mechanisms of protein kinase A (PKA) signaling pathways.

Crafted with utmost precision and utilizing state-of-the-art technology, this polyclonal antibody exhibits exceptional sensitivity and specificity, ensuring accurate and reliable results. Its high affinity for the phosphorylated PKA alpha cat at Ser338 allows for precise identification and quantification, facilitating comprehensive investigations into the functional role of PKA in various cellular processes.

The PKA alpha cat phospho-Ser338 polyclonal antibody is an invaluable tool for researchers seeking to unravel the complexities of PKA signaling cascades. Its application extends to a wide range of research areas, including cell biology, molecular biology, biochemistry, and pharmacology. By enabling the detection and analysis of phosphorylated PKA alpha cat, this antibody opens up new avenues for understanding the intricate regulatory mechanisms governing cellular responses.

With a commitment to excellence, BT Lab ensures the highest quality standards in the production of this polyclonal antibody. Rigorous quality control measures are implemented at every stage of manufacturing, guaranteeing consistent performance and reproducibility. The antibody is supplied in a convenient format, allowing for easy integration into various experimental protocols.

In summary, the PKA alpha cat phospho-Ser338 polyclonal antibody by BT Lab is a cutting-edge research tool that empowers scientists to unravel the complexities of PKA signaling pathways. Its exceptional sensitivity, specificity, and reliability make it an indispensable asset for researchers in the life sciences field. Stay at the forefront of scientific discovery with this remarkable antibody, and unlock new insights into the intricate world of PKA signaling.